TRANSFER AGENT, REGISTRAR AND DIVIDEND DISBURSING AGENT AGREEMENTTransfer Agent, Registrar and Dividend Disbursing Agent Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • British Columbia
ORAGENICS, INC., a company incorporated under the laws of Florida, United States of America, with an office in the City of Alachua, in the State of Florida
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • Florida
THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made and entered into as of the ____ day of April, 2002, by and among Oragenics, Inc., a Florida corporation ("Oragenics") and the purchasers listed on Schedule I hereto (each such person a "Seller" and, collectively, the "Sellers").
WARRANT INDENTURE _____________________________________________________________ _____________________________ THIS WARRANT INDENTURE is dated as of March 28, 2003, BETWEEN: ORAGENICS, INC., a Florida company located at 12085 Research Drive, Alachua,...Warrant Indenture • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • British Columbia
COMPUTERSHARE TRUST COMPANY OF CANADA, a trust company incorporated under the laws of Canada and authorized to carry on trust business in the Province of British Columbia and having a branch office at 4th Floor, 510 Burrard Street, Vancouver, British Columbia, V6C 3B9
POOLING AGREEMENTPooling Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • British Columbia
This Agreement is being entered into by the Parties in connection with the proposed distribution (the IPO), by the Issuer, of 2,000,000 Units (the "Units") consisting of one share of common stock (the "Shares"), one half of one Series A warrant (the "Series A Warrants") and one half of one Series B warrant (the "Series B Warrants") by prospectus.
ORAGENICSFinancing Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations
This letter agreement is entered as of the date first written above as an amendment to that certain Agreement between Cornet Capital Corp. ("Cornet") and Oragenics, Inc., formerly known as Oragen ("Oragenics"), dated March 18, 2002 (the "Financing Agreement"). It supercedes and replaces entirely the previous agreement in letter form of even date between us (the "Previous Amendment") amending the Financing Agreement.
Oragenics, Inc. Agency AgreementAgency Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • British Columbia
Oragenics, Inc., a corporation organized under the laws of Florida (the "Company"), proposes to issue and sell to the public in British Columbia and Alberta 2,400,000 Units at a price per Unit of $1.25 (the "Offering Price") by way of initial public offering in the Provinces of British Columbia and Alberta (the "Canadian Qualifying Jurisdictions"). The Company appoints Haywood Securities Inc. (the "Agent") as its exclusive agent and the Agent accepts the appointment and agrees to act as the exclusive agent of the Company to offer the Units for sale under the Prospectus in the Canadian Qualifying Jurisdictions. The Agent shall use all reasonable commercial efforts to sell the Units (on an "all or none" basis) but it is understood and agreed that the Agent shall act as agent only on such reasonable commercial efforts basis and is under no obligation to purchase any Units. Unless otherwise indicated, all dollar amount herein are references to US dollars.
Agreement Regarding Indemnification of Escrow Agent Between Oragenics, Inc. and the University of Florida Research Foundation, Inc.Indemnification Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • Florida
The Agreement is entered into this seventh day of January, 2003, between Oragneics, Inc. ("Oragenics") and the University of Florida Research Foundation, Inc. ("UFRF").
CONSULTING AGREEMENT BETWEENConsulting Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations • Virginia
To: Oragenics, Inc. From: Jeffery D. Hillman Date: March 21, 2003 Gentleman:Payment Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations
Please be advised that I hereby agree not to demand or seek payment from the proceeds of the contemplated initial public offering of units amounts owing to me by Oragenics under Promissory Note dated February 22, 2001.
To: Oragenics, Inc. From: Robert Zahradnik Date: March 21, 2003 Gentleman:Payment Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations
Please be advised that I hereby agree not to demand or seek payment from the proceeds of the contemplated initial public offering of units amounts owing to me by Oragenics under Promissory Notes dated February 28, 1999 and February 22, 2001.
FOURTH AMENDMENT TO LICENSE AGREEMENTSLicense Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations
This Fourth Amendment to the License Agreements dated August 4, 1998 and June 22, 2000 is made as of the ___ day of March, 2003 by and between the University of Florida Research Foundation, Inc. (UFRF), a nonstock, nonprofit Florida corporation, and Oragenics, Inc. (formerly OraGen, Inc.)("Licensee"), a corporation organized and existing under the laws of Florida.
SECOND AMENDMENT TO ESCROW AGREEMENTEscrow Agreement • April 9th, 2003 • Oragenics Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO ESCROW AGREEMENT is made as of March 1, 2003, by and among (i) ORAGENICS, INC. ("Oragenics"), (ii) CORNET CAPITAL CORP. ("Cornet"), and (iii) SUTHERLAND ASBILL & BRENNAN LLP, as Escrow Agent ("SAB").
